Home » Uncategories » Sage Animal Hospital Receives First Halcyon Machine

Sage Animal Hospital Receives First Halcyon Machine

PetCure Oncology at SAGE Treats First Pet Patient with Halcyon

Campbell, CA – September vii, 2017 – It has been a celebrated week for PetCure Oncology, a national provider of cancer care for pets that treated information technology's 1,000th patient on Tuesday.

Meet Peanut, the first Bay Expanse pet treated past PetCure Oncology at SAGE.

The milestones continued on Wednesday, when the visitor'due south newest site – PetCure Oncology at SAGE in the Bay Area – became the first veterinary medical provider in the world to care for a pet for cancer with the brand new Halcyon™ treatment system.

Halcyon is the newest cancer treatment device engineered by Varian Medical Systems, the globe's leading manufacturer of medical devices and software for treating and managing cancer. The avant-garde handling system was recently completed following a v-year engineering process designed to simplify and enhance nearly every attribute of image-guided, intensity-modulated radiation therapy. Halcyon offers increased speed, more than efficient workflow, and sharper precision than previous machines, benefitting both clinicians and patients with an advanced delivery mechanism for radiations therapy.

"This may exist the most momentous event in a calendar week total of exciting milestones," said Scott Milligan, CEO of PetCure Oncology. "Pet owners in northern California will benefit greatly from this synergistic human relationship between PetCure, SAGE and Varian. Our commitment is to provide pet owners with access to the same great treatment options available for human cancer patients. This is another huge step in that direction."

In July, PetCure Oncology and Varian Medical Systems announced a strategic collaboration intended to amend cancer care for pets and back up PetCure'due south goal of building a stronger bridge between human and veterinary cancer intendance. Among other things, the collaboration includes the deployment of six Halcyon units at current or hereafter PetCure Oncology centers.

The first Halcyon was installed concluding month at PetCure Oncology at SAGE in Campbell, California, part of a four-center veterinary specialty network operated by SAGE Centers for Veterinary Specialty and Emergency Intendance. The Campbell location, merely south of San Jose, is the seventh eye in PetCure's rapidly-growing national network. It officially opened last calendar week and delivered its first radiations therapy treatment on Wednesday.

PetCure Oncology CEO Scott Milligan stands next to the first Halcyon unit in veterinarian medicine.

"We have a lot of respect for both PetCure and SAGE," said Chris Toth, Varian'southward President of Global Commercial and Field Operations. "Their commitment to high-quality cancer care for pets is very apparent."

The three leaders in their respective markets are committed to working together for the betterment of pets, pet families, and veterinarians in northern California. The PetCure Oncology at SAGE partnership provides comprehensive cancer care, including access to stereotactic radiosurgery (SRS) provided by an industry-leading team of veterinary radiation oncologists. With the improver of Varian's Halcyon and supporting software platforms, treatments will exist delivered with a level of precision and efficiency on par with the near progressive human oncology providers in the world.

"Nosotros're extremely proud to be the beginning veterinary provider to bring SRS to the Bay Surface area," said Julie Smith, SAGE'southward Managing Partner and Medical Director. "Our core values include innovation and collaboration. The upgrade of our radiations oncology service was fueled past both, and our ability to at present treat more pets and a wider variety of cancers will have a meaningful affect on the lives of pets and pet families in northern California."

Pet Advocates are hands reachable by calling 833-PET-HERO or visiting PetCureOncology.com.

###

Media Contact: Jack Moore | Principal Marketing Officeholder | PetCure Oncology | 847.420.5594 | JMoore@PetCureOncology.com

More than than 6,000 pet families have chosen PetCure Oncology for their domestic dog or cat's cancer therapy. We give your pet a fighting gamble to improve their quality of life. We sympathise. We commit. We will assistance.